Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_1
3
38%
Ph phase_4
3
38%
Ph phase_3
2
25%

Phase Distribution

3

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(4)

Detailed Status

Completed4
Not yet recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (37.5%)
Phase 32 (25.0%)
Phase 43 (37.5%)

Trials by Status

not_yet_recruiting338%
completed450%
active_not_recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingphase_4

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

NCT06851962
not_yet_recruitingphase_1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

NCT07223983
not_yet_recruitingphase_4

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

NCT07251556
not_yet_recruitingphase_4

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

NCT07073053
completedphase_3

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

NCT03552757
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06851962Phase 4

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Active Not Recruiting
NCT07223983Phase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

Not Yet Recruiting
NCT07251556Phase 4

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

Not Yet Recruiting
NCT07073053Phase 4

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

Not Yet Recruiting
NCT03552757Phase 3

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Completed
NCT03061214Phase 3

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)

Completed
NCT03288740Phase 1

A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

Completed
NCT03611322Phase 1

A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8